U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 7

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
ChrX:135290774
GRCh38:
ChrX:136208615
FHL1C221Y, C237Y, C250YAsymmetric septal hypertrophyLikely pathogenic
(Jan 1, 2018)
no assertion criteria provided
2.
GRCh37:
Chr7:128492808
GRCh38:
Chr7:128852754
FLNC, FLNC-AS1Hypertrophic cardiomyopathy 26, Asymmetric septal hypertrophyLikely pathogenic
(Jan 1, 2018)
no assertion criteria provided
3.
GRCh37:
Chr11:47353666
GRCh38:
Chr11:47332115
MYBPC3N1257KPrimary familial dilated cardiomyopathy, Cardiovascular phenotype, not specified,
not provided, Hypertrophic cardiomyopathy
Conflicting interpretations of pathogenicity
(Aug 21, 2022)
criteria provided, conflicting interpretations
4.
GRCh37:
Chr11:47355103
GRCh38:
Chr11:47333552
MYBPC3Heart block, Tachycardia, Asymmetric septal hypertrophy,
Premature ventricular contraction, Dyspnea, Hypertrophic cardiomyopathy,
Noncompaction cardiomyopathy, Cardiovascular phenotype, Left ventricular noncompaction 10,
Hypertrophic cardiomyopathy 4, not providedCardiomyopathy,
Hypertrophic cardiomyopathy 4, Primary familial hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy,
...see more
Pathogenic/Likely pathogenic
(Oct 30, 2022)
criteria provided, multiple submitters, no conflicts
5.
GRCh37:
Chr11:47370092
GRCh38:
Chr11:47348541
MYBPC3V219LCardiovascular phenotype, Hypertrophic cardiomyopathy 4, Left ventricular noncompaction 10,
not provided, Cardiomyopathy, Hypertrophic cardiomyopathy 4,
Primary familial hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy
Pathogenic/Likely pathogenic
(Dec 23, 2022)
criteria provided, multiple submitters, no conflicts
6.
GRCh37:
Chr14:23884860
GRCh38:
Chr14:23415651
LOC126861897, MHRT, MYH7R1712QHypertrophic cardiomyopathyPathogenic
(Dec 9, 2021)
reviewed by expert panel
FDA Recognized Database
7.
GRCh37:
ChrMT:4300
GRCh38:
ChrMT:4300
MT-TIMitochondrial diseaseLikely pathogenic
(Sep 12, 2022)
reviewed by expert panel
FDA Recognized Database
Format
Items per page
Sort by
Choose Destination